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ABSTRACT
Background:   Due to the COVID-19 pandemic, access to medical care is restricted for nearly 
all non-acute conditions. Due to their status as a vulnerable social group and the inherent 
need for transition-related treatments, transgender people are assumed to be affected 
particularly severely by the restrictions caused by the COVID-19 pandemic.
Methods:   As an ad hoc collaboration between researchers, clinicians and 23 community 
organizations, we developed a web-based survey in German that was translated into 26 
languages. Participants were recruited via community sources, social media channels, and 
snowball sampling since May 2020. The present sample is based on the data collected until 
August 9, 2020. We assessed demographical data, health problems, risk factors, COVID-19 
data (e.g., contact history), and the influence of the COVID-19 pandemic on access to 
transgender health care services. To identify factors associated with the experience of 
restrictions, we conducted multiple logistic regression analysis.
Results:   5267 transgender people from 63 upper-middle-income and high-income countries 
participated in the study. Over 50% of the participants had risk factors for a severe course 
of a COVID-19 infection and were at a high risk of avoiding COVID-19 treatment due to the 
fear of mistreatment or discrimination. Access to transgender health care services was 
restricted for 50% of the participants. Male sex assigned at birth and a lower monthly income 
were significant predictors for the experience of restrictions to health care. 35.0% reported 
at least one mental health condition and 3.2% have attempted suicide since the beginning 
of the COVID-19 pandemic.
Discussion:   Transgender people suffer under the severity of the pandemic due to the 
intersections between their status as a vulnerable social group, their high number of medical 
risk factors, and their need for ongoing medical treatment. The COVID-19 pandemic can 
potentiate these vulnerabilities, add new challenges for transgender people, and, therefore, 
can lead to devastating consequences, like severe physical or mental health issues, self-harming 
behavior, and suicidality.
Introduction
Transgender people experience their gender as 
incongruent with the sex assigned at birth. They 
might identify as a binary gender (female, male) 
or outside of the gender binary. People who are 
non-binary might experience their gender as 
moving between male and female (e.g., gender-
fluid) or as situated beyond the gender binary 
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(e.g., genderqueer). Some reject the concept of 
sex and gender at all, either on a personal, or a 
general level (e.g., agender). Transgender health 
care primarily focusses on medical measures to 
support the person’s transition to live their gender 
both physically and socially. This may include 
hormone therapy, gender-affirming surgery, and 
a variety of additional interventions (e.g., voice 
and communication therapy, hair removal (Safer 
& Tangpricha, 2019)). For treatment-seeking 
transgender people these interventions positively 
affect mental health and quality of life and are 
thus considered state-of-the-art treatments 
(Coleman et  al., 2012; Dhejne et  al., 2016; 
Hembree et  al., 2017; Reisner et  al., 2016). 
However, not all transgender people want to 
undergo any of these medical interventions 
(Nieder et  al., 2020), or might have access to it 
(Koehler et  al., 2018; Motmans et  al., 2019).
Transgender communities all around the world 
are highly diverse, depending on cultural back-
ground, socioeconomic factors, legal circum-
stances, and many more influences. Therefore, 
there is no universal narrative that could be 
assumed to represent transgender communities 
globally. However, transgender people have been 
considered to be a vulnerable social group in 
much of the world, many of whom have experi-
enced discrimination and marginalization by soci-
ety, and health care systems in particular (Koch 
et  al., 2020; Reisner et  al., 2016). Access to trans-
gender health care is often restricted due to legal 
requirements, financial barriers, and ‘gatekeeping’ 
health care providers in countries all over the 
world (Fontanari et  al., 2019; Safer et  al., 2016). 
These elements can lead to a negative impact on 
transgender individuals health and quality of life 
(Reisner et  al., 2016).
During to the COVID-19 pandemic access to 
medical care was, and in some areas globally still 
is, restricted for nearly all non-acute medical 
conditions. State health care, as well as private 
practice, were mainly focusing on COVID-19. 
Since transgender individuals often need access 
to medical treatments such as hormone therapy 
(Safer & Tangpricha, 2019), these restrictions are 
likely to have increased psychological distress. 
Due to both their status as a vulnerable social 
group and their need for transition-related 
treatments (Koch et  al., 2020; Reisner et  al., 
2016), this impact may be particularly severe for 
transgender people (Wang, Pan, Liu et  al., 2020).
Even though some authors have already 
addressed the impact of the COVID-19 pandemic 
on transgender people, there remains a dearth of 
evidence. Perez-Brumer and Silva-Santisteban 
(2020) discussed the disparities transgender peo-
ple face in Peru due to binary-based policies as 
a response to the COVID-19 pandemic (only 
women or men are allowed to leave their homes 
on certain weekdays) and how this increasing 
discrimination impacts physical and mental 
health. Van der Miesen and colleagues (2020) 
summarized the intersections between health 
care, human rights, and socioeconomic stress for 
transgender individuals during the COVID-19 
pandemic. They state the need for a joint strategy 
of policy makers, transgender advocates, health 
care providers, and governments. Wang and col-
leagues (2020) refer to the barriers of care for 
transgender people in times of COVID-19 in light 
of evidence from their clinic in Beijing, China. 
The restricted access to hormone treatment was 
associated with high levels of depression and anx-
iety due to the challenge of continuing presenting 
and socially living as their sex assigned at birth. 
All the authors state the need for collaborative 
strategies between relevant stakeholders (e.g., gov-
ernments, health care providers, advocacy groups) 
to actively consider the difficulties faced by the 
transgender population during the COVID-19 
pandemic and the need for high-quality evidence 
to base strategies upon (Perez-Brumer & 
Silva-Santisteban, 2020; van der Miesen et  al., 
2020; Wang, Pan, Liu et  al., 2020).
The current study investigates the impact of the 
COVID-19 pandemic on the health and health 
care of transgender individuals, acknowledging the 
diversity of transgender communities in different 
geographical regions and countries and the variety 
of societal, legal, and medical circumstances. As 
an ad hoc collaboration between researchers, com-
munity members and clinicians from several coun-
tries, the study aims to generate an impression of 
the situation of transgender health care during the 
COVID-19 pandemic in as many countries as pos-
sible. The study aimed to contribute empirical 
evidence on the situation of transgender 
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individuals in times of COVID-19 and, therefore, 
help to develop and implement measures address-




Because of the rapid development of the 
COVID-19 pandemic and the necessity to imple-
ment the study as quick as possible, there was 
no time to apply for financial funding.
The TransCareCovid-19 survey (www.
transcarecovid-19.com), is a web-based survey 
designed to investigate the effects of the 
COVID-19 pandemic on health care for trans-
gender individuals. This cross-sectional study was 
developed by Andreas Koehler, Timo Nieder and 
Joz Motmans in cooperation with local health 
care providers and community members. Several 
members of the research group are transgender 
and/or part of the LGBTQ + community. 
Additional consultation was sought in the con-
struction of the survey by peer and professional 
organizations.
The survey was first developed in German and, 
in cooperation with 23 community organizations 
(for details see www.transcarecovid-19.com), trans-
lated into 26 other languages (Arabic, Azerbaijani, 
Armenian, Bulgarian, Chinese, Croatian, Dutch, 
English, Farsi, French, Georgian, German, 
Hungarian, Italian, Kazakh, Kyrgyz, Macedonian, 
Polish, Portuguese, Romanian, Russian, Serbian, 
Spanish, Swedish, Tajik, Turkish, Ukrainian). The 
English version of the survey was translated by 
local transgender people whose native language 
was the language into which the survey was trans-
lated and who were also fluent in English. 
Therefore, we hoped to ensure both involvement 
of the local transgender community and the use 
of proper terms that a professional translator 
might have not been aware of. Moreover, there 
was no funding for this study to finance a trans-
lation by a professional translator.
The study followed strict ethical guidelines and 
received ethical approval from both  the Local 
Psychological Ethics Committee at the University 
Medical Center MM-NN (No.: LPEK-0130, date: 
01/04/2020), as well as from PP University 
Hospital (BC-07607, date: 15/04/2020). All 
respondents provided informed consent.
Participants
To recognize the heterogeneity of the transgender 
population, the survey was open to anyone who 
identifies, experiences, and/or describes themselves, 
as transgender and were at least 16 years of age. 
The process of participant recruitment was imple-
mented by local community organizations to 
ensure the most effective way to contact transgen-
der people in a certain region or country. Therefore, 
we hoped to enhance acceptance of the study in 
local populations and meet specific requirements 
(e.g., communication channels of local transgender 
communities that were not known to the core 
research team). Moreover, participants were 
recruited via postings by the researchers on 
LGBTIQ+-related social media channels, and 
through snowball sampling.
Data collection
The data collection started in May 2020 and is 
still ongoing. The participant recruitment was 
supported by several scientific and community 
organizat ions ( for  detai ls  see  www.
transcarecovid-19.com). The present sample is 
based on the data collected until August 9, 2020. 
We choose this date as the COVID-19 pandemic 
was slowing down in most countries all over the 
world and our data allowed us to give a com-
prehensive overview on how the first wave of 
COVID-19 affected transgender people. This 
paper consists of analyses of data from 
high-income and upper-middle-income countries 
according to the World Bank country classifica-
tion (World Bank, 2020) only, as participant 
recruitment for lower-middle-income and 
low-income countries started later.
Variables
As there was no funding for this study to pay 
for licensed standardized measures, we decided 
to use open-source measures from previous stud-
ies on transgender health care and develop survey 
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questions by the researchers themselves. Based 
on the works by Eyssel and colleagues (2017), 
Motmans and colleagues (2017), and Koehler and 
colleagues (2018), the survey collects demograph-
ical data regarding age, education, occupational 
status, country of residence, place of residence, 
residence status, living situation, financial income, 
relationship, minority status (person of color, reli-
gious minority, sexual minority, gender minority, 
minority due to disability status, another 
minority), sex assigned at birth, and gender. The 
participants’ country of residence was classified 
by the current World Bank country classification 
by income level (World Bank, 2020). Upper- 
middle-income countries are defined as having a 
gross national income (GNI) per capita of $4,046 
– $12,535. A country with a GNI per capita of 
greater than $12,535 is considered a high-income 
economy. Physical health problems were assessed 
using questions based on established studies (Hill 
et  al., 2016; Motmans et  al., 2017) and free-text 
responses. COVID-19 symptoms, contact history, 
satisfaction with information, knowledge, and 
concerns about COVID-19, were assessed follow-
ing Wang and colleagues using 4-point Likert 
scales (1-highest value, 4-lowest value; for details, 
see Appendix (Wang, Pan, Wan et  al., 2020)). We 
added additional items related to transgender- 
discrimination and avoidance of health care based 
on former studies (Motmans et  al., 2017). Finally, 
data regarding transition-related health care such 
as medical procedures which the respondent has 
undergone, and the influence of the COVID-19 
pandemic on access to transgender health care 
and health-related supplies (e.g., chest binders), 
were assessed based on an established protocol 
(Eyssel et  al., 2017). Depending on the proce-
dures which the respondent had undergone, par-
ticipants were specifically asked about the 
influence of the COVID-19 pandemic on single 
treatments. For example, only participants who 
already used hormones were asked if access to 
their medication was restricted. Fears about 
future restrictions on treatment were investigated 
if participants had already sought or planned the 
treatment. The full survey can be found in the 
supplementary material. Due to the method of 
participant recruitment, access to a web-enabled 
device, social media activity, and technical affinity 
need to be considered as potential biases. By 
encouraging participants to promote the survey 
with their peers we tried to address the issue of 
lacking social media activity. Unfortunately, we 
were not able to provide a paper-pencil version 
of the survey due to the wide range of the study 
and a lack of financial and human resources.
Statistical analysis
Continuous data are presented as mean (SD). 
Categorical data are presented as n (%). Missing 
data were deleted pairwise. To identify factors 
associated with the experience of restrictions to 
transgender health care, we conducted a multiple 
logistic regression analysis. Experiencing restric-
tions in at least one domain (hormone treatment, 
hair removal treatment, surgery, surgical after-
care) was included as dependent variable (yes, 
no). We entered the covariates in two blocks. 
Block 1 included age, education (no formal edu-
cation, primary, secondary, tertiary education), 
relationship (yes, no), minority status (person of 
color, religious minority, sexual minority, gender 
minority), disability (yes, no), sex assigned at 
birth (female, male), and gender (binary, 
non-binary). This block was labeled Demographic 
Characteristics. Block 2 included the following 
aspects of the social environment: Countries’ GNI 
per capita (upper middle-income economy, high- 
income economy), residence status (yes, no), pop-
ulation of place of residence (urban, rural), to 
make ends meet with monthly income (very eas-
ily, easily, fairly easily, with some difficulty, with 
difficulty, with great difficulty), and health insur-
ance (yes, no). This block was labeled Social 
Environment. Cox and Snell’s R 2 and Nagelkerke’s 
R 2 are reported as coefficients of determination. 
To check for violations of assumptions for logistic 
regression such as independence of errors, incom-
plete information from the predictors, diagnostics 
were conducted on all relevant variables. 
Collinearity diagnostics did not reveal significant 
multicollinearity concerns for any of the variables 
in the model. We decided against statistical com-
parisons by country or geographic region. Due 
to the multiplicity of legal frameworks and health 
care systems, comparisons would have had only 
limited validity. However, regional differences are 
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reported descriptively. A p value of <.05 was con-
sidered to be statistically significant. SPSS 24.0 
(IBM Corp. Released 2016. IBM SPSS Statistics 
for Windows, Version 24.0. Armonk, NY: IBM 
Corp.) was used for all statistical analyses.
Role of the funding source
There was no funding for this study. The corre-
sponding author had full access to all the data 
in the study and had final responsibility for the 
decision to submit for publication.
Results
Between May 1, 2020, and August 9, 2020, 7905 
potential participants accessed the survey. 597 
participants did not give informed consent and 
thus were not able to access the survey. Another 
593 participants gave informed consent but did 
not answer any further questions. From the 
remaining 6715 participants, 1223 individuals 
were excluded from the analyses because they 
did not respond to at least 50% of the survey. 
For the present analysis, 225 participants from 
low-income and lower-middle-income countries 
were not included. The final dataset consisted of 
5267 participants.
On average, the present sample is of early mid-
dle age (30·70 years ± 12·06), highly educated 
(60·7% tertiary education), mostly single (48·7%), 
and living in an urban environment (79·9%). 
57·3% were assigned female at birth. 74·0% iden-
tified as binary [trans] man or [trans] woman, 
whereas 21·5% identified as a non-binary gender.
Basic and transgender-related demographics are 
presented in Table 1. Table 2 and Figure 1 show 
the current country of residence of the partici-
pants. Most participants lived in European coun-
tries. Figure 2 gives an overview of the physical 
health problems of the participants. 2768 (52·6%) 
reported a least one acute or chronic condition. 
525 (10·0%) reported that these conditions 
resulted in severe limitations in daily activities, 
1674 (31·8%) reported limitations to some extent. 
509 (9·7%) had no limitations due to their chronic 
condition. 1009 (19·2%) of the participants were 
smokers. 327 (6·2%) used to smoke but had 
recently stopped. 3035 (73·6%) had at least once 
Table 1. Demographics and social situation.
N (%)
Total N° 5267 (100.00%)
Age
Years (Mean [SD]) 30.70 (12.06)
Range 15.00 − 81.00
Education
No formal education 42 (0.8%)
Primary education 354 (6.7%)
Secondary education 1019 (19.3%)
Tertiary education: vocational education and training 608 (11.5%)
Tertiary education: college/university 2589 (49.2%)
Other 302 (5.7%)




Married, living together 424 (8.1%)
Married, but living separately 83 (1.6%)
Registered relationship, living together 82 (1.6%)
Registered relationship, but living separately 37 (0.7%)
Non-registered relationship, living together 669 (12.7%)
Non-registered relationship, but living separately 675 (12.8%)
In more than one relationship 199 (3.8%)
Widowed 14 (0.3%)
Other 198 (3.6%)




Vocational training 226 (4.3%)
Unskilled worker 163 (3.1%)
Employee 1635 (31.0%)
Civil servant 185 (3.5%)
Self-employed 447 (8.5%)
Informal employment 119 (2.3%)
Unemployed 812 (15.4%)
Retired 112 (2.1%)
Unable to work 422 (8.0%)
Other 400 (7.6%)
I cannot or do not wish to answer the question 52 (1.0%)
Minority statusa
Person of color 528 (10.5%)
Religious minority 908 (17.3%)
Sexual minority 4414 (83.8%)
Gender minority 4842 (91.9%)
Minority due to disability status 1438 (27.3%)
Another minority 1013 (19.3%)
Gender
(Trans) man 2141 (40.6%)





I don´t know, I don´t have a preference 144 (2.7%)
Missing 44 (0.8%)
Living according to gender
Never 370 (7.0%)
Occasionally 998 (18.9%)
Almost always 1249 (23.7%)
Always 2619 (49.7%)
Missing 31 (0.6%)
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City or the suburbs or outskirts of a city, or town 4210 (79.9%)
A country village, farm, or home in the countryside 1043 (19.8%)
Missing 14 (0.3%)
Change of living situation due to COVID-19 591 (11.2%)
Missing 10 (0.2%)
Other people living in household 4102 (77.9%)
Missing 0 (0.0%)
Garden, balcony, other outdoor space 4088 (77.6%)
Missing 20 (0.4%)
Distress due to current living situation 2045 (38.8%)
Missing 13 (0.2%)
Making ends meet with the available monthly 
income
Very easily 746 (14.2%)
Easily 990 (18.8%)
Fairly easily 1380 (26.2%)
With some difficulty 1042 (19.8%)
With difficulty 507 (9.6%)
With great difficulty 390 (7.4%)
I don´t want to say 78 (1.5%)
I don´t know 121 (2.3%)
Missing 13 (0.2%)
a Multiple answers were possible.
Table 2. Countries.




















North Macedonia 17 (0.3%)
Russia 61 (1.1%)
Serbia 69 (1.3%)
South Africa 75 (1.4%)
Turkey 181 (3.3%)





































United Kingdom 563 (10.3%)







Upper-middle-income countries 762 (14.5%)
in their life seriously considered suicide, 1827 
(35·1%) had had suicidal thoughts since the 
beginning of the COVID-19 pandemic. 1797 
(34·5%) had had at least once suicide attempt, 
168 (3·2%) have attempted suicide since the 
beginning of the COVID-19 pandemic.
Table 3 gives an overview on COVID-19-
related topics. Participants were quite satisfied 
with the information they received on the 
COVID-19 pandemic (M: 2·13 ± 0·8) and had 
high confidence in medical personnel to diagnose 
COVID-19 (M: 2·01 ± 0·8). Participants assumed 
it as not very likely to be diagnosed with 
COVID-19 (M: 2·90 ± 0·9) and as highly likely to 
survive a COVID-19 infection (M: 1·63 ± 0·8). 
They were concerned that members of their fam-
ilies or close friends will contract COVID-19 (M: 
2·09 ± 0·9).
Table 4 summarizes the influence of the 
COVID-19 pandemic on transgender health care. 
Of the 4699 participants that had undergone 
transition-related treatment or planned to do so, 
2875 (61·2%) feared access restrictions to trans-
gender health care in the future due to the 
COVID-19 pandemic. Of the 3463 participants 
that had already undergone transition-related 
treatment, 1706 (49·3%) experienced restrictions 
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Figure 1. Participants current country of residence.
Figure 2. Acute and chronic conditions associated with a risk of a severe course of a COVID-19 infection.
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Table 3. COVID-19 health care, avoidance, and knowledge.
COVID-19 health care
Tested for COVID-19 within the last 14 days 130 (2.5%)
In quarantine within the last 14 days 1481 (28.1%)
Diagnosed with COVID-19 20 (0.4%)
Recovered from COVID-19 14 (0.3%)
Direct contact with a person diagnosed with COVID-19 109 (2.1%)
Indirect contact with a person diagnosed with COVID-19 245 (4.7%)
Contact with a person suspected to have COVID-19 818 (15.5%)
COVID-19 health care avoidance
Avoided COVID-19 testing because of fear of mistreatment 295 (5.6%)
Avoided COVID-19 testing because of fear of discrimination 356 (6.8%)
Will avoid COVID-19 testing because of fear of mistreatment 761 (14.4%)
Will avoid COVID-19 testing because of fear of discrimination 888 (16.9%)
COVID-19 knowledge
Transmission via droplet infection 5040 (95.7%)
Increasing number of infections worldwide 5091 (96.7%)
Increasing number of deaths worldwide 5067 (96.2%)
Increasing number of survivals worldwide 4592 (87.2%)
Table 4. Restrictions regarding transgender health care due to the COVID-19 pandemic.
N (%a)
Accessed at least one transgender health care procedure 3463 (65.7%)
Experienced restrictions in access to transgender health care 1706 (49.3%)
Accessed or planned at least one transgender-related treatment procedure 4699 (89.2%)
Fear restrictions to transgender health care in the future 2875 (61.2%)
Access to hormones currently restricted 676 (21.8%)
I cannot get a prescription 162 (24.0%)
I cannot get an appointment with my hormone prescriber 249 (36.8%)
A scheduled appointment was canceled without replacement 110 (16.3%)
An appointment has been postponed 81 (12.0%)
I am afraid to go to a medical provider or a hospital 189 (28.0%)




Fear that access to hormones will be affected in the future 2316 (44.0%)
Access to hair removal treatment currently restricted 665 (63.4%)
Fear that access to hair removal treatment will be affected in the future 776 (44.1%)
Surgery canceled or postponed
Yes 454 (15.6%)
Not yet, but I expect it will 568 (19.5%)
Problems with aftercare for recent surgery 344 (56.4%)
I cannot get an appointment for aftercare 45 (13.1%)
A scheduled appointment was canceled without replacement 70 (20.3%)
An appointment has been postponed 84 (24.4%)
Complications (e.g., secondary bleeding) have not been treated 22 (6.4%)
I am afraid to go to a doctor or a hospital 41 (11.9%)
Other 82 (23.8%)
Fear that surgical aftercare will be affected in the future 316 (21.9%)
Access restricted to
medical material necessary after surgery (e.g., vaginal dilators) 160 (3.0%)
other material (e.g., binders, packing material) 651 (12.4%)
non-medical supplies (e.g., wigs, make-up) 860 (16.3%)
Alternative options for accessing counseling services 1271 (47.9%)
Undergoing mental health care (e.g., for depression) 2055 (39.0%)
Access to mental health care limited 1271 (61.9%)
Fear that access to mental health care will be affected in the future 1035 (50.4%)
Member of a support group 1543 (28.5%)
Access to support groups limited 1067 (69.2%)
a Percentages refer to the number of participants who assessed a certain transgender health service, not to the total sample.
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in access to transgender health care services. A 
breakdown of the descriptive results by countries 
and regions can be found in the supplementary 
material. A multiple logistic regression analysis 
revealed that the sex assigned at birth and the 
adequacy of the monthly income predicted the 
experience of restrictions to transgender health 
care significantly. Participants assigned male at 
birth (OR: 2·239) and individuals with a lower 
income (OR: 1·102) were at greater risk of expe-
riencing restrictions to transgender health care 
procedures (Table 5).
Discussion
The current study provides empirical insights into 
how the COVID-19 pandemic affects the health 
care of transgender people in upper-middle-in-
come and high-income countries. Over 50% of 
our participants had risk factors for a severe 
course of a COVID-19 infection and were at a 
high risk of avoiding testing or treatment of a 
potential COVID-19 infection due to fear of mis-
treatment and/or discrimination. Transgender 
health care was highly affected by the COVID-19 
pandemic, with almost half of participants expe-
riencing some sort of restricted access to health 
care. Restricted access to transgender health care 
applied rather universally to all transgender indi-
viduals, with a male sex assigned at birth and a 
lower monthly income as the only significant 
predictors.
We found that over 50% of transgender indi-
viduals have risk factors for a severe course of a 
COVID-19 infection (i.e. preexisting medical con-
ditions, being a smoker (Holman et  al., 2020; 
Razzaghi et  al., 2020; Vardavas & Nikitara, 2020; 
Zhou et  al., 2020)). Compared with that, 23.5% 
of the working population in the EU and 
one-third of the European general population 
over 15 suffer from chronic conditions according 
to the Organization for Economic Cooperation 
and Development (OECD, 2016). Similar numbers 
were found for other OECD countries (OECD, 
2019). Only in the US is the prevalence of chronic 
conditions between the transgender and the gen-
eral population approximately equal, with 6 out 
of 10 adults having a chronic condition (Centers 
for Disease Control and Prevention, 2020). 
Additionally, our participants were likely to avoid 
COVID-19 testing or care because of fears of 
discrimination or mistreatment. This was true 
even though they were aware of the potential 
severity of COVID-19. This avoidance of care 
could even worsen their risk for serious conse-
quences of COVID-19.
We found that access to all transgender health 
care interventions was restricted due to the 
COVID-19 pandemic. This could be especially 
important for those who access ongoing treat-
ments such as hormone therapy (Hembree et  al., 
2017). Hormone therapy is considered one of the 
most important treatment options for many trans-
gender individuals and is highly associated with 
better mental health and quality of life (White 
Hughto & Reisner, 2016). An interruption of a 
hormone therapy is not associated with physical 
risks when gonadectomy was not performed. 
Table 5. Multiple regression analysis regarding the experience of restrictions to transgender health care.
b ± SE CI p OR (95% CI)
Demographics
Age 0.000 ± 0.003 −0.007 − 0.006 0.899 1.000 (0.993, 1.006)
Education −0.013 ± 0.067 −0.148 − 0.119 0.850 0.987 (0.869, 1.121)
Relationship 0.033 ± 0.079 −0.123 − 0.201 0.677 1.033 (0.886, 1.205)
POC 0.158 ± 0.145 −0.129 − 0.436 0.269 1.171 (0.885, 1.550)
Religious minority −0.083 ± 0.118 −0.320 − 0.144 0.466 0.920 (0.742, 1.142)
Sexual minority 0.000 ± 0.116 −0.220 − 0.236 0.997 1.215 (0.891, 1.657)
Gender minority 0.194 ± 0.157 −0.104 − 0.490 0.217 1.081 (0.891, 1.657)
Disability 0.077 ± 0.095 −0.097 − 0.276 0.388 0.380 (0.903, 1.657)
Sex assigned at birth 0.967 ± 0.082 0.809 − 1.136 0.001 2.239 (2.239, 3.092)
Non-binary gender −0.034 ± 0.119 −0.262 − 0.213 0.767 0.966 (0.769, 1.214)
Social Environment
Countries GNI per capita −0.167 ± 0.115 −0.392 − 0.056 0.153 0.846 (0.677, 1.057)
Residence status −0.312 ± 0.254 −0.845 − 0.182 0.212 0.732 (0.449, 1.191)
Population place of residence 0.106 ± 0.102 −0.092 − 0.320 0.292 1.111 (0.913, 1.354)
Monthly income 0.097 ± 0.028 0.045 − 0.150 0.003 1.102 (1.043, 1.164)
Health insurance 0.093 ± 0.175 −0.255 − 0.422 0.600 1.098 (0.792, 1.521)
Constant 0.754 ± 0.554 −0.283 − 1.840 0.172 0.808
R2 0.063 (Cox & Snell), 0.084 (Nagelkerke). Model χ2 (15) = 186.693, p = 0.000.
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However, mental health risks must be considered 
(Deutsch, 2016). Stopping hormone treatment is 
often associated with a return of some features 
related to the sex assigned at birth (e.g., the 
return of menstruation). Moreover, mood swings 
and symptoms of depression and anxiety can 
occur (Coleman et  al., 2012; Deutsch, 2016; 
Hembree et  al., 2017). There is a risk of psycho-
logical distress for the twenty percent of our 
sample whose hormones have been, or still are, 
restricted due to the pandemic. This association 
has also been reported by Wang and colleagues 
in their clinic in Beijing, China (Wang, Pan, Liu 
et  al., 2020). The same may well be true for hair 
removal treatments. The management of unwanted 
body hair could be challenging for transgender 
people and could negatively influence a person’s 
transition to live their gender both physically and 
socially (Ginsberg et  al., 2016). While hair 
removal might not have the same impact on gen-
der affirmation as hormone treatment has, it is 
often performed as a supportive measure as hor-
mone treatment alone could be insufficient to 
eliminate hair growth (Deutsch, 2016). As a pop-
ulation, transgender individuals are already expe-
riencing poor social support, and are at high risk 
of discrimination and harassment, which is asso-
ciated with poorer mental health and decreased 
quality of life (Başar et  al., 2016; Johns et  al., 
2018; Koch et  al., 2020; Reisner et  al., 2016); 
consequently, the restrictions in access to health 
care may affect transgender people to a greater 
extent than the general population. This higher 
vulnerability might also intersect with other 
minority statuses, such as being a person of color 
(Burgwal et  al., 2019; Jefferson et  al., 2013).
All these transgender-specific issues caused by 
the COVID-19 pandemic need to be addressed by 
both structural changes as well as counseling ser-
vices (e.g., peer counseling) and mental health care 
professionals. However, due to the COVID-19 pan-
demic, access to these measures is limited, too. 
For 43·4% of the participants who assessed coun-
seling services, the access to those was restricted. 
61·9% of those who undergo mental health care 
(e.g., for a preexisting affective disorder) experi-
enced access restrictions. Only half of the partic-
ipants had alternative options for accessing 
counseling services (e.g., online consultations). 
Additionally, even access to low-threshold services, 
like support groups, was limited for two thirds of 
their members. In light of the available data, the 
COVID-19 pandemic and its associated restric-
tions, combined with the systemic inequalities 
transgender people face in almost every country 
in the world, appears to have had a significant 
impact on the (mental) health of transgender peo-
ple. Tragically, our study found that more than 
one third of our sample had had suicidal thoughts 
and 3·2% had attempted suicide since the begin-
ning of the pandemic. And even though no causal 
conclusions can be drawn based on our 
cross-sectional study, it seems reasonable to assume 
that many of these suicidal attempts are linked to 
the situation caused by the COVID-19 pandemic. 
Indeed, at the least this association ought to be a 
warning sign that transgender people might be 
disproportionally affected by COVID-19.
Some treatment options for transgender people 
such as genital surgeries (Safer & Tangpricha, 
2019) have been highly restricted due to the 
COVID-19 pandemic, too. At the time of the 
data analysis, approximately 15·6% of surgeries 
were already canceled and another 19·5% of the 
participants expected their surgery to be canceled. 
Additionally, aftercare for recent surgery was also 
restricted. As genital surgery is considered an 
important treatment option to increase quality of 
life and reduce psychological distress in trans-
gender people (Coleman et  al., 2012; Murad 
et  al., 2010), a postponement of these procedures 
can negatively impact a person’s well-being. 
Especially regarding surgical aftercare, restrictions 
could lead to serious health concerns like wound 
infections or disorders of wound healing (Coleman 
et  al., 2012). Moreover, due to insecurities caused 
by the postponement of surgery, mental health 
problems could occur which should be addressed 
by counseling services or mental health profes-
sionals when possible. However, as the access to 
these services is restricted too, problems associ-
ated with postponed surgeries might not be 
addressed sufficiently and could intersect with 
already existing distress such as restrictions to 
accessing hormone treatment.
All potential distress caused by restrictions to 
transgender health care might be further affected 
by social and socio-economic circumstances, as 
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already reported by Perez-Brumer and 
Silva-Santisteban (2020). We found that one third 
of our participants had difficulties earning enough 
to live from with their available monthly income 
and another third experienced distress due to 
their current living situation. However, using 
regression analysis, we only found a male sex 
assigned at birth and a lower monthly income to 
be significant predictors for the experience of 
restrictions to transgender health care. The sig-
nificant association to a male sex assigned at 
birth could be due to a greater stigma toward 
transgender people assigned male at birth (Budge 
et al., 2013). The association between the monthly 
income and a higher risk of restrictions to trans-
gender health care with an OR of 1·102 could 
be considered weak. Therefore, it seems that the 
COVID-19 pandemic hits the transgender pop-
ulation in higher-middle-income and high-income 
countries in its entirety and that there aren´t any 
major protective social factors.
The strength of our study is that it includes a 
high number of participants from several coun-
tries all over the world. This is important as, 
with a number of 6.8 to 355 per 100,000, trans-
gender people are only a small group within the 
general population (Collin et  al., 2016; Zhang 
et  al., 2020). Moreover, the study was developed 
and conducted by transgender researchers in 
close cooperation with community organizations. 
Therefore, we intentionally took power differences 
between researchers and study subjects into 
account and tried to ensure tangible outcomes 
for the community.
The major limitation of our study is that the 
results cannot be generalized to all upper 
middle-income and high-income countries. 
Transgender communities are highly diverse, 
depending on country, geographical region, and 
cultural background. It was not the purpose of 
this study to tell a universal narrative of how the 
COVID-19 pandemic impacted transgender people. 
Rather, we intended to quickly generate valid evi-
dence on the various effects of COVID-19 on 
transgender health care measures recruiting a sam-
ple as large and as diverse as possible by following 
a research approach based on community involve-
ment (T’Sjoen et  al., 2017). Therefore, our results 
should not be overinterpreted to avoid creating a 
simplified, universal description of how the 
COVID-19 pandemic affected all transgender peo-
ple. This limitation is also reflected by the low 
amount of variance explained by the regression 
analysis we calculated (Table 5). Other studies, 
however, used approaches that allowed them to 
draw more conclusive interpretation of their 
results, even though they have notably smaller 
sample sizes from a smaller number of countries 
and regions. We consider the type of data collec-
tion another potential limitation of our study due 
to access to the internet being a necessity. This 
could have excluded participants with low income 
or without experience with digital technology. As 
the participant recruitment was carried out by 
local community organizations, we hoped to min-
imize the effects of this limitation and ensured 
the most effective way to contact transgender peo-
ple in a certain region or country. Our sample 
was comparable to previous studies, in terms of 
gender or education, for example (Eyssel et  al., 
2017; Koehler et  al., 2018). As there is still a 
dynamic COVID-19 situation, with increasing and 
decreasing numbers of infections and changing 
national measures to address these, this research 
also did not explore international comparisons. In 
countries where COVID-19 has been more effec-
tively suppressed the impacts of COVID-19 could, 
therefore, be lower. Moreover, we only analyzed 
data from higher middle-income and high-income 
countries, which is why the results cannot be gen-
eralized to countries with lower GNI per capita. 
However, as participant recruitment in lower 
middle-income countries and low-income coun-
tries appeared to be difficult (but is still ongoing), 
the clear need for evidence of how COVID-19 
affects transgender people led us to focus on the 
present data. We currently strive to provide data 
from lower middle-income countries and 
low-income countries as soon as possible.
In sum, it appears that the COVID-19 pan-
demic has an extraordinary impact on the trans-
gender population in upper-middle-income and 
high-income countries, and that transgender peo-
ple might suffer under the severity of the pan-
demic even more than the general population. 
This is due to the intersections between their 
status as a vulnerable social group, their high 
number of medical risk factors, and their need 
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for ongoing medical treatment. The COVID-19 
pandemic can potentiate these vulnerabilities, add 
new challenges for transgender people, and can 
therefore lead to devastating consequences such 
as severe physical or mental health issues, 
self-harming behavior, and even suicidality.
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